Skip Navigation

European Heart Journal 1991 12(Supplement F):83-87; doi:10.1093/eurheartj/12.suppl_F.83
Copyright © 1991 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schmitz, W.
Right arrow Articles by Scholz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmitz, W.
Right arrow Articles by Scholz, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 The European Society of Cardiology

The role of alpharadrenergic and muscarinic receptors in cardiac function

W. Schmitz, T. Eschenhagen, U. Mende, F. U. Moller and H. Scholz

Abteilung Allgemeine Pharmakologie, Universitdts-Krankenhaus Eppendorf, MartinistraBe 52,D-W-2000 Hamburg 20,Germany

Correspondence: Prof. Dr. med. Wilhelm Schmitz, Pharmakologisches Institut, Universitäts-Krankenhaus Eppendorf, Universität Hamburg, Martinistraβe 52, D-2000 Hamburg 20, Germany

The positive inotropic effect of an alpha1-adrcnoccptor agonist, such as phenylephrine, is accompanied by an increase in the presumed second messenger, inositol 1,4,5-trisphosphate (1,4,5-IP3) and inositol 1,3,4,5-tetrakisphosphate (1,3,4,5-IP4), which may release calcium from the sarcoplasmic reticulum (SR) and/or facilitate calcium entry from the extracellular space. In addition, phenylephrine sensitizes the contractile proteins for calcium. Alpha1-adrenergic positive inotropic effects are enhanced in heart muscle preparations from cardio-myopathic hamsters and are reduced in heart muscle preparations from human failing myocardium.

How the negative inotropic effects of M-cholinoceptor agonists work in the presence of cAMP-increasing agents in ventricular heart muscle preparations is discussed. It involves cAMP-reduction, an increase in cGMP and activation of phosphatase activity. In a rat model, chronic beta-adrenergic stimulation leads to increased sensitivity of rat ventricular tissue for the negative inotropic effect of the M-cholinoceptor agonist, carbachol. This might be due to facilitated signal transduction via increased G1 proteins. In human ventricular tissue from hearts with end-stage heart failure, due to idiopathic dilated cardiomyopathy (IDC), an increased G1 protein has also been found. However, the negative inotropic effects of carbachol were unchanged. The data indicate that changes in alpha-adrenergic and M-cholinergic responses in the heart may depend on underlying causes that induce changes.

Key Words: Alpha1-adrenoceptors • M-cholinoceptors • positive inotropic effects • negative inotropic effects • G proteins • failing heart


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.